Evidence for neuroendocrine function of a unique splicing form of TCF7L2 in human brain, islets and gut
Variants in the TCF7L2 gene remain the strongest genetic associations with increased risk of type 2 diabetes. Recently, we identified a unique splicing form of TCF7L2 expressed in pancreatic islets, pancreas and colon and detected by assay ‘ex13-13b’. The expression of ex13-13b strongly correlated with proinsulin in glucose-stimulated pancreatic islets, suggesting a potential role for this form in the development of type 2 diabetes. The goal of this study was to further characterise this unique TCF7L2 splicing form in human tissues.
We used a panel of 34 human tissues and 80 human cell lines to measure the expression of assay ex13-13b with use of quantitative RT-PCR.
The highest expression of assay ex13-13b was detected in several areas of the brain (hypothalamus/thalamus, occipital lobe) and in neuronal cell line SHS5Y5. Low expression was confirmed in pancreatic islets, small intestine, pancreas and colon, while no expression was detected in other human tissues and cell lines. The expression of assay ex13-13b correlated with the gene for cocaine- and amphetamine-regulated transcript (CART, also known as CARTPT) in a panel of human tissues (n = 12, r = 0.85, p = 0.00046), pancreatic islets (n = 23, r = 0.62, p = 0.0016) and colon (n = 98, r = 0.54, p < 0.0001).
The significant correlation between expression of a unique splicing form of TCF7L2, named here TCF7L2-NE, and CART, the gene for an anorexigenic neurohormone expressed in the central and peripheral nervous system, suggests that these transcripts may share neuroendocrine functions important for brain, gut and pancreatic islets.
- Grant, SF, Thorleifsson, G, Reynisdottir, I (2006) Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 38: pp. 320-323 CrossRef
- Scott, LJ, Mohlke, KL, Bonnycastle, LL (2007) A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316: pp. 1341-1345 CrossRef
- Prokunina-Olsson, L, Welch, C, Hansson, O (2009) Tissue-specific alternative splicing of TCF7L2. Hum Mol Genet 18: pp. 3795-3804 CrossRef
- Mountjoy, PD, Rutter, GA (2007) Glucose sensing by hypothalamic neurones and pancreatic islet cells: AMPle evidence for common mechanisms?. Exp Physiol 92: pp. 311-319 CrossRef
- Fang, M, Li, J, Blauwkamp, T, Bhambhani, C, Campbell, N, Cadigan, KM (2006) C-terminal-binding protein directly activates and represses Wnt transcriptional targets in Drosophila. EMBO J 25: pp. 2735-2745 CrossRef
- Willer, CJ, Speliotes, EK, Loos, RJ (2009) Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet 41: pp. 25-34 CrossRef
- Arora, S, Anubhuti, (2006) Role of neuropeptides in appetite regulation and obesity: a review. Neuropeptides 40: pp. 375-401 CrossRef
- Nazwar, TA, Glassmann, A, Schilling, K (2009) Expression and molecular diversity of Tcf7l2 in the developing murine cerebellum and brain. J Neurosci Res 87: pp. 1532-1546 CrossRef
- Wang, R, Liu, X, Hentges, ST (2004) The regulation of glucose-excited neurons in the hypothalamic arcuate nucleus by glucose and feeding-relevant peptides. Diabetes 53: pp. 1959-1965 CrossRef
- Broberger, C, Holmberg, K, Kuhar, MJ, Hokfelt, T (1999) Cocaine- and amphetamine-regulated transcript in the rat vagus nerve: a putative mediator of cholecystokinin-induced satiety. Proc Natl Acad Sci USA 96: pp. 13506-13511 CrossRef
- Wierup, N, Sundler, F (2006) CART is a novel islet regulatory peptide. Peptides 27: pp. 2031-2036 CrossRef
- Evidence for neuroendocrine function of a unique splicing form of TCF7L2 in human brain, islets and gut
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
Volume 53, Issue 4 , pp 712-716
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Brain–gut–islets axis
- Gene expression
- Neuroendocrine regulation
- Type 2 diabetes
- Industry Sectors
- Author Affiliations
- 1. Laboratory of Translational Genomics, National Cancer Institute, National Institutes of Health, 8717 Grovemont Circle, Bethesda, 20892-4605, MD, USA
- 2. Lillehei Heart Institute, Department of Medicine, The Developmental Biology Center, University of Minnesota, Minneapolis, MN, USA